- Investing Ideas
- /
- Polish Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Polish Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
16
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
16 companies
Bioceltix
Market Cap: zł561.4m
Engages in the development of stem cell-based biopharmaceuticals for veterinary use.
BCX
zł114.00
7D
19.0%
1Y
59.2%
BIOTON
Market Cap: zł312.5m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł3.64
7D
1.1%
1Y
3.4%
Genomed Spólka Akcyjna
Market Cap: zł33.0m
Provides DNA analysis and congenital diseases diagnostic services in Poland.
GEN
zł25.00
7D
-3.8%
1Y
-15.5%
Mabion
Market Cap: zł147.6m
A biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland.
MAB
zł9.13
7D
-1.6%
1Y
-42.9%
Poltreg
Market Cap: zł168.4m
A biotechnology company, develops therapies for autoimmune diseases.
PTG
zł36.10
7D
3.1%
1Y
-35.8%
Celon Pharma
Market Cap: zł1.3b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.
CLN
zł24.10
7D
-0.8%
1Y
60.7%
genXone
Market Cap: zł18.2m
Operates in the biotechnology industry in Poland and internationally.
GX1
zł5.46
7D
1.9%
1Y
-11.4%
Green Zebras Spolka Akcyjna
Market Cap: zł12.6m
Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.
GRZ
zł9.50
7D
-3.1%
1Y
n/a
NanoGroup
Market Cap: zł94.9m
Operates as a biotechnology company in Poland.
NNG
zł3.00
7D
-1.2%
1Y
192.7%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł156.2m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł33.50
7D
-2.9%
1Y
-57.6%
Bioerg Spólka Akcyjna
Market Cap: zł13.8m
Bioerg Spólka Akcyjna engages in the retail trade of food and chemical products for humans and animals in Poland.
BER
zł0.14
7D
0%
1Y
-17.6%
Stem Cells Spin
Market Cap: zł7.3m
Operates as a biotechnology company in Poland.
SCS
zł0.18
7D
10.0%
1Y
-66.5%
Ryvu Therapeutics
Market Cap: zł594.2m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł25.70
7D
13.7%
1Y
-52.9%
Urteste
Market Cap: zł111.9m
Engages in the research and development of diagnostic tests for cancers.
URT
zł79.40
7D
-4.3%
1Y
-24.4%
Molecure
Market Cap: zł159.8m
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland.
MOC
zł7.91
7D
-6.5%
1Y
-50.4%
Cannabis Poland
Market Cap: zł17.2m
Engages in the retail and wholesale of products based on hemp containing cannabidiol (CBD) in Poland.
CBD
zł0.35
7D
5.6%
1Y
-39.0%